BackTarsus Pharmaceuticals Overview
Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Target Price

Where could TARS trade next? Consensus target price: $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$73

Average Target Price

$103.0041.1% upside

6 analysts in the last 4 months

High: $116 | Low: $89

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-24Goldman SachsAndrea Newkirk$11658.9% upsideOpen
2026-09-16Barclays$11050.7% upsideOpen
2026-09-08Jefferies$10543.8% upsideOpen
2026-08-12OppenheimerMazahir Alimohamed$10037% upsideOpen
2026-08-03Mizuho Securities$9834.2% upsideOpen
2026-07-21GuggenheimEddie Hickman$8921.9% upsideOpen
2026-02-05Goldman Sachs$686.8% downsideOpen
2025-12-08Barclays$10037% upsideOpen
2025-11-20Mizuho Securities$10037% upsideOpen
2025-11-06Goldman SachsAndrea Tan$5130.1% downsideOpen
2025-10-20H.C. Wainwright$8820.5% upsideOpen
2025-05-02GuggenheimEddie Hickman$8415.1% upsideOpen
2025-03-06Jefferies$5820.5% downsideOpen
2025-01-27BarclaysBalaji Prasad$6215.1% downsideOpen
2025-01-22OppenheimerFrancois Brisebois$721.4% downsideOpen
2024-09-23OppenheimerFrancois Brisebois$6313.7% downsideOpen
2024-05-13H.C. WainwrightOren Livnat$6116.4% downsideOpen

Tarsus Pharmaceuticals (TARS) FAQ

Tarsus Pharmaceuticals (TARS) currently reports a target price of $100. Use the charts on this page to explore Tarsus Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Tarsus Pharmaceuticals is $100, about 41.1% upside from the current share price of $73.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $100, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tarsus Pharmaceuticals, and consider following TARS for alerts when major investors trade the stock.

Tarsus Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $100. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARS with unrelated industries.